Ong, JS;
Dixon-Suen, SC;
Han, X;
An, J;
Fitzgerald, R;
Buas, M;
Gammon, MD;
... MacGregor, S; + view all
(2021)
A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization.
Nature Communications
, 12
, Article 246. 10.1038/s41467-020-20368-w.
Preview |
PDF
A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization.pdf - Other Download (1MB) | Preview |
Abstract
Previous Mendelian randomization (MR) studies on 25-hydroxyvitamin D (25(OH)D) and cancer have typically adopted a handful of variants and found no relationship between 25(OH)D and cancer; however, issues of horizontal pleiotropy cannot be reliably addressed. Using a larger set of variants associated with 25(OH)D (74 SNPs, up from 6 previously), we perform a unified MR analysis to re-evaluate the relationship between 25(OH)D and ten cancers. Our findings are broadly consistent with previous MR studies indicating no relationship, apart from ovarian cancers (OR 0.89; 95% C.I: 0.82 to 0.96 per 1 SD change in 25(OH)D concentration) and basal cell carcinoma (OR 1.16; 95% C.I.: 1.04 to 1.28). However, after adjustment for pigmentation related variables in a multivariable MR framework, the BCC findings were attenuated. Here we report that lower 25(OH)D is unlikely to be a causal risk factor for most cancers, with our study providing more precise confidence intervals than previously possible.
Type: | Article |
---|---|
Title: | A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1038/s41467-020-20368-w |
Publisher version: | http://doi.org/10.1038/s41467-020-20368-w |
Language: | English |
Additional information: | © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
Keywords: | Cancer epidemiology, Cancer genetics, Cancer prevention |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology |
URI: | https://discovery.ucl.ac.uk/id/eprint/10170841 |
Archive Staff Only
View Item |